ReviewTranslational lung cancer research2013

Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?

Bartomeu Massuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.